Report Detail

Pharma & Healthcare Global Inhaler Medicine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4524148
  • |
  • 17 March, 2023
  • |
  • Global
  • |
  • 98 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Inhaler Medicine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Inhalers contain either short-acting or long-acting medicines. Short-acting medicines relax and open the breathing tubes in the lungs. These are called rescue inhalers because they work quickly and help “rescue” a person if breathing suddenly becomes difficult. Long-acting inhalers are used daily.
This report is a detailed and comprehensive analysis for global Inhaler Medicine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Inhaler Medicine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Inhaler Medicine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Inhaler Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Inhaler Medicine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Inhaler Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Inhaler Medicine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, AstraZeneca, Chiesi, Boehringer Ingelheim and Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Inhaler Medicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Short-acting Medicines
Long-acting Medicines
Market segment by Application
COPD
Asthma
Other
Major players covered
GSK
AstraZeneca
Chiesi
Boehringer Ingelheim
Novartis
Teva
Organon
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Inhaler Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Inhaler Medicine, with price, sales, revenue and global market share of Inhaler Medicine from 2018 to 2023.
Chapter 3, the Inhaler Medicine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inhaler Medicine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Inhaler Medicine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Inhaler Medicine.
Chapter 14 and 15, to describe Inhaler Medicine sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Inhaler Medicine
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Inhaler Medicine Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Short-acting Medicines
    • 1.3.3 Long-acting Medicines
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Inhaler Medicine Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 COPD
    • 1.4.3 Asthma
    • 1.4.4 Other
  • 1.5 Global Inhaler Medicine Market Size & Forecast
    • 1.5.1 Global Inhaler Medicine Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Inhaler Medicine Sales Quantity (2018-2029)
    • 1.5.3 Global Inhaler Medicine Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 GSK
    • 2.1.1 GSK Details
    • 2.1.2 GSK Major Business
    • 2.1.3 GSK Inhaler Medicine Product and Services
    • 2.1.4 GSK Inhaler Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 GSK Recent Developments/Updates
  • 2.2 AstraZeneca
    • 2.2.1 AstraZeneca Details
    • 2.2.2 AstraZeneca Major Business
    • 2.2.3 AstraZeneca Inhaler Medicine Product and Services
    • 2.2.4 AstraZeneca Inhaler Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 AstraZeneca Recent Developments/Updates
  • 2.3 Chiesi
    • 2.3.1 Chiesi Details
    • 2.3.2 Chiesi Major Business
    • 2.3.3 Chiesi Inhaler Medicine Product and Services
    • 2.3.4 Chiesi Inhaler Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Chiesi Recent Developments/Updates
  • 2.4 Boehringer Ingelheim
    • 2.4.1 Boehringer Ingelheim Details
    • 2.4.2 Boehringer Ingelheim Major Business
    • 2.4.3 Boehringer Ingelheim Inhaler Medicine Product and Services
    • 2.4.4 Boehringer Ingelheim Inhaler Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.5 Novartis
    • 2.5.1 Novartis Details
    • 2.5.2 Novartis Major Business
    • 2.5.3 Novartis Inhaler Medicine Product and Services
    • 2.5.4 Novartis Inhaler Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Novartis Recent Developments/Updates
  • 2.6 Teva
    • 2.6.1 Teva Details
    • 2.6.2 Teva Major Business
    • 2.6.3 Teva Inhaler Medicine Product and Services
    • 2.6.4 Teva Inhaler Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Teva Recent Developments/Updates
  • 2.7 Organon
    • 2.7.1 Organon Details
    • 2.7.2 Organon Major Business
    • 2.7.3 Organon Inhaler Medicine Product and Services
    • 2.7.4 Organon Inhaler Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Organon Recent Developments/Updates

3 Competitive Environment: Inhaler Medicine by Manufacturer

  • 3.1 Global Inhaler Medicine Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Inhaler Medicine Revenue by Manufacturer (2018-2023)
  • 3.3 Global Inhaler Medicine Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Inhaler Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Inhaler Medicine Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Inhaler Medicine Manufacturer Market Share in 2022
  • 3.5 Inhaler Medicine Market: Overall Company Footprint Analysis
    • 3.5.1 Inhaler Medicine Market: Region Footprint
    • 3.5.2 Inhaler Medicine Market: Company Product Type Footprint
    • 3.5.3 Inhaler Medicine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Inhaler Medicine Market Size by Region
    • 4.1.1 Global Inhaler Medicine Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Inhaler Medicine Consumption Value by Region (2018-2029)
    • 4.1.3 Global Inhaler Medicine Average Price by Region (2018-2029)
  • 4.2 North America Inhaler Medicine Consumption Value (2018-2029)
  • 4.3 Europe Inhaler Medicine Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Inhaler Medicine Consumption Value (2018-2029)
  • 4.5 South America Inhaler Medicine Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Inhaler Medicine Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Inhaler Medicine Sales Quantity by Type (2018-2029)
  • 5.2 Global Inhaler Medicine Consumption Value by Type (2018-2029)
  • 5.3 Global Inhaler Medicine Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Inhaler Medicine Sales Quantity by Application (2018-2029)
  • 6.2 Global Inhaler Medicine Consumption Value by Application (2018-2029)
  • 6.3 Global Inhaler Medicine Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Inhaler Medicine Sales Quantity by Type (2018-2029)
  • 7.2 North America Inhaler Medicine Sales Quantity by Application (2018-2029)
  • 7.3 North America Inhaler Medicine Market Size by Country
    • 7.3.1 North America Inhaler Medicine Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Inhaler Medicine Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Inhaler Medicine Sales Quantity by Type (2018-2029)
  • 8.2 Europe Inhaler Medicine Sales Quantity by Application (2018-2029)
  • 8.3 Europe Inhaler Medicine Market Size by Country
    • 8.3.1 Europe Inhaler Medicine Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Inhaler Medicine Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Inhaler Medicine Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Inhaler Medicine Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Inhaler Medicine Market Size by Region
    • 9.3.1 Asia-Pacific Inhaler Medicine Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Inhaler Medicine Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Inhaler Medicine Sales Quantity by Type (2018-2029)
  • 10.2 South America Inhaler Medicine Sales Quantity by Application (2018-2029)
  • 10.3 South America Inhaler Medicine Market Size by Country
    • 10.3.1 South America Inhaler Medicine Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Inhaler Medicine Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Inhaler Medicine Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Inhaler Medicine Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Inhaler Medicine Market Size by Country
    • 11.3.1 Middle East & Africa Inhaler Medicine Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Inhaler Medicine Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Inhaler Medicine Market Drivers
  • 12.2 Inhaler Medicine Market Restraints
  • 12.3 Inhaler Medicine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Inhaler Medicine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Inhaler Medicine
  • 13.3 Inhaler Medicine Production Process
  • 13.4 Inhaler Medicine Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Inhaler Medicine Typical Distributors
  • 14.3 Inhaler Medicine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Inhaler Medicine. Industry analysis & Market Report on Inhaler Medicine is a syndicated market report, published as Global Inhaler Medicine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Inhaler Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,756.16
    4,134.24
    5,512.32
    3,215.52
    4,823.28
    6,431.04
    526,489.20
    789,733.80
    1,052,978.40
    290,127.60
    435,191.40
    580,255.20
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report